The role of FeNO testing in asthma care: A case study

This case study has been carried out by Carol Stonham MBE, a Medical Advisory Board member. Carol has worked as a registered nurse since 1986, shifting from acute hospital care to primary care by 1990. She currently works at the Gloucestershire ICB, leading the Respiratory Clinical Programme Group and co-leading the NHSE South West Respiratory Network.

The role of FeNO testing in asthma care: A case study

Image Credit: NObreath

This case study aims to emphasize the value of Fractional exhaled Nitric Oxide (FeNO) testing in asthma care and explain why the NObreath® FeNO device is the product of choice. The NObreath® conducts a non-invasive test that measures nitric oxide levels in exhaled breath. High levels of nitric oxide may indicate airway inflammation, a common characteristic of allergic asthma.

Asthma is a common respiratory condition affecting approximately 5.4 million individuals in the UK. A significant number of asthma-related deaths occur each year, many of which are believed to be preventable. This underscores the critical need to increase awareness about FeNO testing and its essential role in the diagnosis and management of asthma.

Carol says, “When looking into the different devices, the NObreath® suited what I was looking for. I wanted something that had a really good approval process as I wanted something that would be reliable. I wanted something that was going to be easy for the patients to use but also easy to teach the healthcare professionals to use. The cost always comes into it, this is something we always need to be careful about within the NHS. Finally, it needed to be something that would offer a sustainable service for a long time.”

The role of FeNO testing in asthma care: A case study

Image Credit: NObreath

Carol continues:

I remember one gentleman who came to me who had asthma for quite a long time, most of his life, but was a patient who used his inhalers as and when he fancied and had really poor inhaler technique, and as a result had really poor control of his asthma. He really felt that he was doing the right thing, so we went through the process of explaining what asthma is, how the inhalers work, explaining the inflammatory nature and then carried out a FeNO test to measure his FeNO levels and demonstrate this to him.

He was really shocked that even though he thought his asthma was well controlled, it wasn’t. He was receptive to me helping him to use his inhalers with better technique and using them more regularly. He came back to see me 4 weeks later and he felt like a whole new man which was fantastic and his FeNO had dropped considerably. So, this is a really good intervention to get control of asthma symptoms.

The role of FeNO testing in asthma care: A case study

Image Credit: NObreath

Watch the case study

This case study demonstrates the advantages of utilizing the NObreath FeNO device while also highlighting the impact of FeNO testing in asthma care.

Revolutionising Asthma Care: FeNO Breath Test Insights with Carol Stonham

Video Credit: NObreath

Featuring Carol Stonham, the study underscores the NObreath’s user-friendliness, making it ideal for both adults and children. It also showcases how FeNO testing enhances asthma care by providing more accurate insights for tailored treatment. Ultimately, this study illustrates why the NObreath® FeNO device is the optimal product for supporting asthma diagnosis and management.

References and further reading

  1. Asthma + Lung UK (2021). What Is Asthma? (online). Available at: https://www.asthmaandlung.org.uk/conditions/asthma/what-asthma.

About NObreath

The NObreath® is a FeNO device by Bedfont® Scientific Ltd. which can be used to measure airway inflammation for the management and diagnosis of asthma. 

Our mission is to help improve asthma diagnosis & management of adults and children worldwide through FeNO measuring. Our purpose is to make FeNO measuring more accessible globally, with the creation of an effective yet cost-efficient FeNO device and equally low cost consumables.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Mar 10, 2025 at 9:41 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NObreath. (2025, March 10). The role of FeNO testing in asthma care: A case study. News-Medical. Retrieved on March 10, 2025 from https://www.news-medical.net/whitepaper/20250310/The-role-of-FeNO-testing-in-asthma-care-A-case-study.aspx.

  • MLA

    NObreath. "The role of FeNO testing in asthma care: A case study". News-Medical. 10 March 2025. <https://www.news-medical.net/whitepaper/20250310/The-role-of-FeNO-testing-in-asthma-care-A-case-study.aspx>.

  • Chicago

    NObreath. "The role of FeNO testing in asthma care: A case study". News-Medical. https://www.news-medical.net/whitepaper/20250310/The-role-of-FeNO-testing-in-asthma-care-A-case-study.aspx. (accessed March 10, 2025).

  • Harvard

    NObreath. 2025. The role of FeNO testing in asthma care: A case study. News-Medical, viewed 10 March 2025, https://www.news-medical.net/whitepaper/20250310/The-role-of-FeNO-testing-in-asthma-care-A-case-study.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.